A supplier of injection molding services and tooling to medical device OEMs, RenyMed has opened a dedicated Secondary Operations Center for medical component decorating. It has also installed a new press at its Baldwin Park, CA, facility.
The 500-square-foot Secondary Operations Center expands RenyMed’s value-added services, including laser marking, pad printing, sub-assembly, and other post-molding operations. Laser marking, in particular, has a long history at RenyMed, dating back several years when company president Steve Raiken started using the technique to optimize assembled heart valve sizers.
When customers found out about RenyMed’s laser-marking capability, they learned that the black permanent mark stands out better than other product identification processes, Raiken told PlasticsToday. “Recently we developed a laser-based process to produce a white mark on black acetal. The part is used to meter dosage. The customer had been using pad printing but found the mark would wear off over time and did not have the dosage accuracy needed,” explained Raiken. The laser mark, by contrast, is crisp, more precise for metering, and permanent. “It makes the customer’s device more user friendly because it is easy to read. We also can serialize lot numbers with our laser,” added Raiken. The company has also provided pad printing for many years, which customers use for part identification and decoration for user instructions.
The company also has taken delivery of a new 30-ton Sumitomo micro-injection molding machine, bringing the total number of presses to 16. “We have had precision micro machining for 10 years and now have the capability for molding with 10-micron tolerances,” said Raiken in a prepared statement.
RenyMed is riding a wave of rising demand for medical contract manufacturing, which is forecast to reach a compound annual growth rate of 11.5% globally through 2026, according to a report from MarketsandMarkets. The global growth is partly a consequence of delayed medical procedures that are now being scheduled as society re-opens, but, says Raiken, in the United States it’s also attributable to post-pandemic reshoring and nearshoring of manufacturing operations.
On the macro side, “Asia is a more difficult place to do business because of COVID travel restrictions and increased political risks. Our customers have recognized the risks to global supply chains and are rethinking these strategies,” said Raiken.
From a micro point of view, RenyMed is well positioned to serve those customers. “We offer a lower capital cost solution to medical device development with our modular tooling,” said Raiken. The company’s mold-making department takes a modular building block approach to mold design and production, with modular components in stock for fast delivery.
The company’s expertise in injection molding and mold making combined with its vertical integration ensures that customers have a “straight path to production.”
RenyMed is exhibiting at Medical Design & Manufacturing (MD&M) West in Anaheim, CA, next month at booth 2468. The event is held at the Anaheim Convention Center on Aug. 10 to 12, 2021. For more information about MD&M West, as well as Plastec West and several other co-located shows and the Design. Engineer. Build. conference program, visit the MD&M West site. Click here to register to attend.